Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
CellReady
- Development stage
- Phase 2
- Lead developer
- Cell-Easy
- Modality
- Stem Cell Therapies → Cell Therapies
- Administration
- Intravenous
01
Overview
CellReady is an allogeneic adipose-derived mesenchymal stem cell (AdMSC) therapy developed by Cell-Easy in collaboration with the University Hospital, Toulouse (CHU Toulouse). It is currently being investigated in the Phase I/II A3D (Adipose Adult stem cells in Alzheimer's Disease) clinical trial for the treatment of mild to moderate Alzheimer's disease. Administered via intravenous injection, CellReady is designed to leverage the regenerative and immunomodulatory properties of mesenchymal stem cells. The therapy aims to reduce neuroinflammation, modulate systemic and local immune responses, and promote neurogenesis, potentially addressing the underlying pathology of Alzheimer's disease and slowing cognitive decline.
- Brand names
- CellReady
- Other names
- allogeneic adipose-derived mesenchymal stem cellsAdMSC
Beyond the preview
Go deeper on CellReady.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on CellReady.